BETHESDA, Md., Dec. 13, 2016 -- India Globalization Capital, Inc. (NYSE-MKT:IGC) announces today that Ram Mukunda, CEO of IGC, will participate as a panelist at the New York State Society of CPAs’ Marijuana Symposium to be held Dec. 13 in New York City.
To date, 28 states and Washington, DC, have legalized marijuana for medical and/or recreational use. The Compassionate Care Act was passed in New York State in July 2014, allowing the controlled use of medical marijuana. As the marijuana industry continues to grow rapidly, as well as generate jobs and revenue, CPAs have been asked to provide their services to businesses that cater to the medical marijuana industry.
Debra Borchardt, financial journalist and contributor to Forbes will moderate a panel of experts who will address practical business, banking and legal issues in New York State. The panel features six distinguished speakers including New York State Sen. Liz Krueger and IGC’s CEO, Ram Mukunda.
About the NYSSCPA
Founded in 1897, the New York State Society of CPAs is the premiere professional membership association representing the interests of a membership of more than 26,000 licensed CPAs and other financial professionals practicing in New York State, and encompassing all areas of practice including in government, education, technology, nonprofit, real estate, healthcare and industry.
About IGC
In the United States, we develop phytocannabinoid-based therapies. IGC has assembled a portfolio of patent filings that encompasses the indications of Pain, Medical Refractory Epilepsy and Cachexia using cannabinoids. We are based in Bethesda, Maryland.
Our website: www.igcinc.us. Twitter @IGCIR Facebook.com/IGCIR/
Contact Information: Claudia Grimaldi 301-983-0998


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 



